Front > MARKET


Perrigo CEO Murray Kessler Photo: Perrigo PR Perrigo launches generic version of Teva's ProAir

ProAir HFA is one of Teva's important branded products.

Dror Ben-Asher RedHill buys AstraZeneca constipation drug rights

The Israeli drug developer will pay $67.5 million for Movantik, which treats opioid-induced constipation.

Eyal Waldman "Those worrying about privacy have things to hide"

Mellanox founder and CEO Eyal Waldman doesn't care if tech companies know everything about him.

Eldad Fresher Mizrahi Tefahot Q4 profit more than doubles

Mizrahi Tefahot Bank's board of directors have decided to distribute a dividend of NIS 176 million on fourth quarter profits.

Shai Novik Photo: Eyal Yitzhar Enlivex plummets after raising cash at discount

Enlivex Therapeutics exploited yesterday's rise in its share price to raise $8 million.

Shekel Photo: ASAP Creative Shekel strengthens after rate kept unchanged

Since the previous interest rate decision, the shekel has strengthened by 3% in terms of the nominal effective exchange rate, the Bank of Israel said.

Teva Teva digital asthma inhaler wins FDA nod

The ArmonAir Digihaler is for the treatment of asthma in patients 12 years and older.

Biotech development, photo: Shutterstock Drug developer PolyPid to file for Wall Street IPO

The company raised $50 million six months ago from its existing shareholders, and has now raised a total of $105 million.

Shai Novik Photo: Eyal Yitzhar Israel's Enlivex reports drug could help COVID-19 patients

Enlivex Therapeutics is increasing production of Allocetra, for treating patients with multisystem failure.

El Al Boeing 787 Dreamliner  photo: PR El Al can manage without state aid

The Tel Aviv Stock Exchange is the airline's platform for raising capital or debt to cope with a difficult business situation, argues Yaniv Pagot.

Teva Photo: Sivan Faraj Teva shed 37% of Israel workforce in two years

Teva had 3,961 employees in Israel at the end of 2019, a reduction of 2,284  in two years, including 932 in 2019.

Zadik Bino Bino bets well on FIBI and against Paz

Forced to sell his controlling stake in either Paz or First International Bank, Zadik Bino chose the share the soared rather than the share which plunged.

cyber  image: Shutterstock Cybersecurity insurance co At-Bay raises $34m

The Israeli company helps businesses navigate risk with continuous vulnerability monitoring. As part of the insurance policy.

St. Petersburg Israel-Canada, Electra sell St. Petersburg land for $40m

The buyer is Russian real estate company Setl City, which will build housing units on the land.

Anat Cohen-Dayag Compugen expands agreement with BMS

Israeli drug discovery company Compugen is conducting three cancer treatment trials this year, two of them with Bristol-Myers Squibb.

SolarEdge panels Photo: PR SolarEdge soars on strong Q4 results

The Israeli solar energy company has seen its market cap break through the $6 billion barrier.

Shekel Photo: ASAP Creative Shekel weakens as possible rate cut looms

The Bank of Israel Monetary Committee meets next Monday to decide on the interest rate and 50% of analysts see the bank cutting the rate from 0.25% to 0.1%.

Medical devices Photo: Shutterstock ASAP Creative Integer buys Israeli medical device co Inomec

Inomec will become Integer's Israel development and sales center.

Avishai Abrahami Photo: Yonatan Bloom Wix worth over $8b as company reports 2019 results

The Israeli DIY website company sees collections exceeding $1 billion in 2020, compared with $832.5 million in 2019.

Avi Gabbay / Photo: Cadya Levy Cellcom to keep Golan as independent brand

Cellcom has come to the conclusion that it has much to learn from Golan Telecom.

Micah Kaufmann Photo: Omer Hacohen Gig economy co Fiverr jumps on Q4 results

Fiverr's guidance for 2020 is higher for revenue and lower for net loss than the market forecasts.

Kare Schultz Photo: Shlomi Yosef Teva CEO: We have to launch new products

Kare Schultz told Teva's annual press conference that streamlining and optimization won't be enough to get the company back to substantial growth.

Mori Arkin and Uri Geiger Exalenz Bioscience sold at NIS 165m valuation

The price at which the company is being sold is 97% lower than the price at which trading in the share began in 2007.

Rami Levy  / Photo: Shlomi Yosef Rami Levy to open post office in supermarket

Israel Postal Company is expanding its cooperation with retailers.

Dairy farm  photo: Eyal Izhar New Zealand co LIC buys 50% Afimilk stake

The New Zealand farming cooperative is buying the stake in the dairy farm systems company from Kibbutz Afikim and Fortissimo.

Zvi Barenboim  / Photo: Tamar Matsafi Barenboim buys Somoto's app distribution activity

The $10 million acquisition price could rise as high as $34.3 million, depending on performance.

Eldad Fresher Mizrahi Tefahot CEO Eldad Fresher steps down

Fresher is the fourth CEO of a major Israeli bank to resign in the past year.

Nir Zuk Nir Zuk slams Check Point's lack of ambition

The Palo Alto Networks founder and CTO blasts Check Point for putting too much emphasis on profit rather than investing in growth.

El Al plane  / Photo: Yochai Mussi El Al to launch Tel Aviv - London Stansted flights

The Israeli carrier, which last operated flights from London Stansted in 2009, will launch a five-times a week service starting June 28.

Raviv Zoller / Photo: Natali Cohen Kadosh Israel Chemicals buys US precision agriculture co Growers

The acquisition of Growers Holdings is part of Israel Chemicals strategy of enhancing its digital services.

Gil Sharon and Avi Gabbay Cellcom signs binding agreement to buy Golan Telecom

The merger will make Cellcom, Israel's largest mobile phone operator with 3.4 million subscribers.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018